Keyphrases
Transcriptional Response
100%
Decitabine
100%
Erythroid
42%
Interferon-α (IFN-α)
28%
RNA Sequencing (RNA-seq)
14%
In Vitro Study
14%
Clinical Response
14%
Bone Marrow Samples
14%
Acute Myeloid Leukemia
14%
Myelodysplastic Syndrome
14%
Inter-patient
14%
Pharmacologic
14%
Primary Bone
14%
Statistical Power
14%
Tissue Culture
14%
Molecular Changes
14%
Patient Treatment
14%
Molecular Events
14%
In Vivo Applications
14%
Transcriptomics
14%
Days of Therapy
14%
Leukemia Patients
14%
Single-cell RNA Sequencing (scRNA-seq)
14%
Transcriptional Signature
14%
Epigenetic Signature
14%
Related Pathway
14%
Hypomethylation
14%
Whole-genome Bisulfite Sequencing
14%
Serum Half-life
14%
Endogenous Retroviral Element
14%
Global Hypomethylation
14%
Power Required
14%
Pharmacology, Toxicology and Pharmaceutical Science
Myelodysplastic Syndrome
100%
Decitabine
100%
Interferon
28%
RNA-Sequencing
28%
Acute Myeloid Leukemia
14%
Bisulfite
14%
Biochemistry, Genetics and Molecular Biology
Decitabine
100%
RNA Sequence
28%
Interferon
28%
Epigenetics
14%
In Vitro Study
14%
Myeloid
14%
Tissue Culture
14%
Sample Size
14%
Transcriptomics
14%
Plasma Half Life
14%
Bisulfite Sequencing
14%
Genomics
14%